Search Results 701-710 of 11613 for VEO-IBD

1. Veliparib and Topotecan Hydrochloride in Treating Patients with Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer - Mayo Clinic

   Veliparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as topotecan hydrochloride ...

2. Application Process - Interstitial Lung Disease and Pulmonary Vasculitis Fellowship (Minnesota) - Mayo Clinic College of Medicine & Science

   The application process for the Interstitial Lung Disease and Pulmonary Vasculitis Fellowship at Mayo Clinic School of Graduate Medical Education in ...

3. A Study to Evaluate Family Experiences and Advice on Diagnosis and Support (FEADS) - Mayo Clinic

   About this study. The purpose of this study is to survey individuals and families on their experience of receiving a diagnosis of a sex chromosome ...

4. Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer - Mayo Clinic

   BRAF V600E is a specific mutation (change) in the BRAF gene, which makes a protein that is involved in sending signals in cells and in cell growth. It may ...

5. Overview - Virology, Vector and Vaccine Engineering: Michael A. Barry - Mayo Clinic Research

   Targeting cells. Dr. Barry's team engineers new ways to get genes into cells and amplify those genes and the proteins that they produce.

6. Intraoperative magnetic resonance imaging (iMRI) - Mayo Clinic

   Neurosurgeons rely on iMRI to guide them in removing brain tumors and treating other conditions such as epilepsy.

7. A Study to Evaluate Brentuximab Vedotin or Placebo in Combination With Lenalidomide and Rituximab in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) - Mayo Clinic

   The purpose of tis study is to evaluate whether adding brentuximab vedotin helps two drugs work better to treat patients with diffuse large B-cell lymphoma ( ...

8. A Study to Evaluate Preemptive Therapy in Hepatitis C Organ Transplant Recipients - Mayo Clinic

   Both drugs are FDA-approved. Mavyret™ is currently used commercially to treat Hepatitis C and Zetia® is used commercially to treat high cholesterol.

9. A Study to Evaluate Preventative Saphenous Nerve Neurectomy in Primary Total Knee Arthroplasty - Mayo Clinic

   The purpose of this study is to evaluate the incidence of chronic knee pain at 6 months following primary total knee arthroplasty. Secondary outcomes include ...

10. Study to Validate Methods Assessment of Inflammatory Skin Disease - Mayo Clinic

    About this study. The purpose of this study is to assess the degree of signal alterations or attenuation in formalin-fixed vs. fresh skin biopsy specimens ...